• mRNA drugs promise transformative therapies but struggle to enter cells intact. • UConn scientists mimic viral capsid design to encapsulate mRNA in protective shells. • The engineered vesicles deliver full-length mRNA efficiently without fragmentation. • In vitro tests show rapid uptake by target cells and robust protein expression. • This viral‑inspired strategy could enhance cancer, genetic disease, and vaccine therapies. • Findings published in ACS Nano highlight a promising delivery platform for next‑generation mRNA medicines.
Article Summaries:
- Researchers at the University of Connecticut have demonstrated a novel method for delivering messenger RNA (mRNA) therapeutics into cells by mimicking viral packaging mechanisms. By encapsulating mRNA in a virus‑like structure, the team achieved efficient, intact entry into target cells while maintaining safety. This approach could enhance the therapeutic potential of mRNA for conditions such as cancer. The findings, published in ACS Nano, suggest a promising alternative to current delivery systems that often fragment or degrade mRNA before it reaches its cellular destination.
Sources: